UniProt ID | FBX43_HUMAN | |
---|---|---|
UniProt AC | Q4G163 | |
Protein Name | F-box only protein 43 | |
Gene Name | FBXO43 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 708 | |
Subcellular Localization | ||
Protein Description | Required to establish and maintain the arrest of oocytes at the second meiotic metaphase until fertilization. Probably acts by inhibiting the anaphase-promoting complex/cyclosome (APC/C) ubiquitin ligase. Probably recognizes and binds to some phosphorylated proteins and promotes their ubiquitination and degradation (Probable).. | |
Protein Sequence | MSFKDKDERISCLEAYVTLTSKSSRFTDETEILKMSQRHSGQAGTEAGNGADSPPIVNSKYSTFRDFCSTSSFQDSGYNELKSCSFDNIDKEYLGKKEKGPTLLYEHPETSGLGLTHPLESPTQKKKCILPRKEKDKTPELCETPKISGKKCLPRRRLNVSFALLKGDFESQNSSLESSISQVINLEKNIPSSASGFSRANNFSPLVTSTLKTEEVTSCSQKLRLNFSQQKTSTIDDSKDDCSLFEVECISPIQGNNFKDSITHDFSDSSLCINDENACPELLGSSVSGTTCGTDEDIFVTPISNLVANIRFNASQILSPSPEVRGSISTPEDSGFNSLSLEKSEDSLSDQEGSFQELLQKHKGTPKVGDTIRKTRHLGRSRRLSTLREQSSQSETEEEKQIVHPDSEKRAAAASAISEGQLSSDESGDLTFSLKNLSKTPALQLVHELFMKSKRKRLQENSGHEFLEQGDGEKIAVLQCILAGLIGKKMGIEKLDILTELKYRNLKHILAMVLESLTAESLCSVWKVSRNWREIVVQDKNANRRRKFYITQLKTDSEGAVLNVEDAATRLQLLNRSALRSVQAQARIPGSQREQGSTLSPWGEVLTPLASSSVTHLSSKQEEYVKVAKTLFTDEALKPCPRCQSPAKYQPYKKRGLCSRTACGFDFCVLCLCAYHGSEECSRGAAKPRNRKDALPGSAQSKRNLKRL | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
18 | Phosphorylation | SCLEAYVTLTSKSSR HEEEEEHHHHCCCCC | 16.19 | 28555341 | |
20 | Phosphorylation | LEAYVTLTSKSSRFT EEEEHHHHCCCCCCC | 25.41 | 28555341 | |
53 | Phosphorylation | EAGNGADSPPIVNSK CCCCCCCCCCCCCCC | 31.85 | 25159151 | |
76 | Phosphorylation | STSSFQDSGYNELKS CCCCCCCCCCHHHHC | 32.18 | 15753281 | |
121 | Phosphorylation | GLTHPLESPTQKKKC CCCCCCCCCCCCCCC | 40.71 | 25159151 | |
138 | O-linked_Glycosylation | PRKEKDKTPELCETP CCCCCCCCCCCCCCC | 31.93 | 29237092 | |
198 | Phosphorylation | PSSASGFSRANNFSP CCCCCCCCCCCCCCC | 33.73 | - | |
234 | Phosphorylation | FSQQKTSTIDDSKDD CCCCCCCCCCCCCCC | 33.39 | 16407128 | |
334 | Phosphorylation | SISTPEDSGFNSLSL CCCCCCCCCCCCCCC | 43.55 | 15753281 | |
344 | Phosphorylation | NSLSLEKSEDSLSDQ CCCCCCCCCCCCCCC | 36.94 | 24850871 | |
347 | Phosphorylation | SLEKSEDSLSDQEGS CCCCCCCCCCCCCCH | 26.22 | 29083192 | |
349 | Phosphorylation | EKSEDSLSDQEGSFQ CCCCCCCCCCCCHHH | 41.00 | 25159151 | |
385 | Phosphorylation | LGRSRRLSTLREQSS HCHHHHHHHHHHHHC | 24.47 | 23532336 | |
499 | Phosphorylation | IEKLDILTELKYRNL CCHHHHHHHHHHCCH | 39.34 | 23403867 | |
503 | Phosphorylation | DILTELKYRNLKHIL HHHHHHHHCCHHHHH | 19.84 | 23403867 | |
507 | Ubiquitination | ELKYRNLKHILAMVL HHHHCCHHHHHHHHH | 31.95 | - | |
551 | Phosphorylation | RRRKFYITQLKTDSE CCEEEEEEEEECCCC | 19.23 | - | |
607 | Phosphorylation | SPWGEVLTPLASSSV CCCHHHHHHHHHCCC | 22.79 | - | |
618 | Phosphorylation | SSSVTHLSSKQEEYV HCCCCCCCCCHHHHH | 28.08 | - | |
619 | Phosphorylation | SSVTHLSSKQEEYVK CCCCCCCCCHHHHHH | 44.72 | - | |
698 | Phosphorylation | RKDALPGSAQSKRNL HHCCCCCCHHHHHHH | 22.61 | 29083192 | |
701 | Phosphorylation | ALPGSAQSKRNLKRL CCCCCHHHHHHHHCC | 33.04 | 29083192 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
234 | T | Phosphorylation | Kinase | CAMK2A | Q9UQM7 | PSP |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of FBX43_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
CDC27_HUMAN | CDC27 | physical | 25161877 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Phosphorylation | |
Reference | PubMed |
"CaMKII and polo-like kinase 1 sequentially phosphorylate thecytostatic factor Emi2/XErp1 to trigger its destruction and meioticexit."; Hansen D.V., Tung J.J., Jackson P.K.; Proc. Natl. Acad. Sci. U.S.A. 103:608-613(2006). Cited for: PHOSPHORYLATION AT THR-234. |